Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Clinical Trial ID NCT01697527

Rank	Title	Journal	Year	PubWeight™‹?›
1	Engineered T cells: the promise and challenges of cancer immunotherapy.	Nat Rev Cancer	2016	1.51
2	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2013	1.31
3	Trial watch: Dendritic cell-based interventions for cancer therapy.	Oncoimmunology	2013	1.09
4	Trial Watch: Adoptive cell transfer for anticancer immunotherapy.	Oncoimmunology	2013	0.95
5	Optimizing dendritic cell-based approaches for cancer immunotherapy.	Yale J Biol Med	2014	0.85
6	Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.	Front Immunol	2015	0.82
7	Imaging Biomarkers in Immunotherapy.	Biomark Cancer	2016	0.81
8	Targeting CD8+ T-cell tolerance for cancer immunotherapy.	Immunotherapy	2014	0.81
9	Immunotherapy in pediatric malignancies: current status and future perspectives.	Future Oncol	2014	0.78
10	Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.	Eur J Cardiothorac Surg	2015	0.77
11	Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy.	Immunotargets Ther	2015	0.75